Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax
(Excluding IV Therapy)
It typically presents as macrocytic megaloblastic anemia and neurological impairments, including sensory and motor disfunctions, predominantly in the lower extremities, ataxia, and in more advanced stages cognitive decline progressing to dementia, as well as psychiatric disturbances ( Subclinical B12 deficiency, however, is far more prevalent, affecting up to 26% of the general population
Ongoing tiredness, numbness, or unexplained anemia should lead to proper testing rather than guesswork
US$ 22.98
US$ 27.61
US$ 28.91
US$ 25.68
US$ 29.86
US$ 21.94
